These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21500269)

  • 1. R-flurbiprofen improves axonal transport in the Tg2576 mouse model of Alzheimer's disease as determined by MEMRI.
    Smith KD; Paylor R; Pautler RG
    Magn Reson Med; 2011 May; 65(5):1423-9. PubMed ID: 21500269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased axonal transport rates in the Tg2576 APP transgenic mouse: improvement with the gamma-secretase inhibitor MRK-560 as detected by manganese-enhanced MRI.
    Wang FH; Appelkvist P; Klason T; Gissberg O; Bogstedt A; Eliason K; Martinsson S; Briem S; Andersson A; Visser SA; Ivarsson M; Lindberg M; Agerman K; Sandin J
    Eur J Neurosci; 2012 Nov; 36(9):3165-72. PubMed ID: 22958226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease.
    Smith KD; Kallhoff V; Zheng H; Pautler RG
    Neuroimage; 2007 May; 35(4):1401-8. PubMed ID: 17369054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo axonal transport deficits in a mouse model of fronto-temporal dementia.
    Majid T; Ali YO; Venkitaramani DV; Jang MK; Lu HC; Pautler RG
    Neuroimage Clin; 2014; 4():711-7. PubMed ID: 24936422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.
    Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M
    Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI.
    Kim J; Choi IY; Michaelis ML; Lee P
    Neuroimage; 2011 Jun; 56(3):1286-92. PubMed ID: 21338698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy in a transgenic model of Alzheimer's disease.
    Aytan N; Choi JK; Carreras I; Kowall NW; Jenkins BG; Dedeoglu A
    Exp Neurol; 2013 Dec; 250():228-238. PubMed ID: 24120437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.
    Imbimbo BP; Del Giudice E; Cenacchi V; Volta R; Villetti G; Facchinetti F; Riccardi B; Puccini P; Moretto N; Grassi F; Ottonello S; Leon A
    Pharmacol Res; 2007 Apr; 55(4):318-28. PubMed ID: 17292621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoid X receptor-alpha mediates (R )-flurbiprofen's effect on the levels of Alzheimer's beta-amyloid.
    You X; Zhang YW; Chen Y; Huang X; Xu R; Cao X; Chen J; Liu Y; Zhang X; Xu H
    J Neurochem; 2009 Oct; 111(1):142-9. PubMed ID: 19659691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent.
    Stock N; Munoz B; Wrigley JD; Shearman MS; Beher D; Peachey J; Williamson TL; Bain G; Chen W; Jiang X; St-Jacques R; Prasit P
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2219-23. PubMed ID: 16455248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
    J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.
    Eriksen JL; Sagi SA; Smith TE; Weggen S; Das P; McLendon DC; Ozols VV; Jessing KW; Zavitz KH; Koo EH; Golde TE
    J Clin Invest; 2003 Aug; 112(3):440-9. PubMed ID: 12897211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI.
    Gallagher JJ; Zhang X; Ziomek GJ; Jacobs RE; Bearer EL
    Neuroimage; 2012 Apr; 60(3):1856-66. PubMed ID: 22500926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
    Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
    Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
    Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
    J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging Enables Ca2+ Overload and Apoptosis Induced by Amyloid-β Oligomers in Rat Hippocampal Neurons: Neuroprotection by Non-Steroidal Anti-Inflammatory Drugs and R-Flurbiprofen in Aging Neurons.
    Calvo-Rodríguez M; García-Durillo M; Villalobos C; Núñez L
    J Alzheimers Dis; 2016 Jul; 54(1):207-21. PubMed ID: 27447424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.